651 related articles for article (PubMed ID: 22153892)
1. Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts.
Joensuu H; Vehtari A; Riihimäki J; Nishida T; Steigen SE; Brabec P; Plank L; Nilsson B; Cirilli C; Braconi C; Bordoni A; Magnusson MK; Linke Z; Sufliarsky J; Federico M; Jonasson JG; Dei Tos AP; Rutkowski P
Lancet Oncol; 2012 Mar; 13(3):265-74. PubMed ID: 22153892
[TBL] [Abstract][Full Text] [Related]
2. Validation of the Joensuu risk criteria for primary resectable gastrointestinal stromal tumour - the impact of tumour rupture on patient outcomes.
Rutkowski P; Bylina E; Wozniak A; Nowecki ZI; Osuch C; Matlok M; Switaj T; Michej W; Wroński M; Głuszek S; Kroc J; Nasierowska-Guttmejer A; Joensuu H
Eur J Surg Oncol; 2011 Oct; 37(10):890-6. PubMed ID: 21737227
[TBL] [Abstract][Full Text] [Related]
3. Which is the optimal risk stratification system for surgically treated localized primary GIST? Comparison of three contemporary prognostic criteria in 171 tumors and a proposal for a modified Armed Forces Institute of Pathology risk criteria.
Goh BK; Chow PK; Yap WM; Kesavan SM; Song IC; Paul PG; Ooi BS; Chung YF; Wong WK
Ann Surg Oncol; 2008 Aug; 15(8):2153-63. PubMed ID: 18546045
[TBL] [Abstract][Full Text] [Related]
4. Physician Underestimation of the Risk of Gastrointestinal Stromal Tumor Recurrence After Resection.
Guérin A; Sasane M; Keir CH; Gauthier G; Macalalad AR; Wu EQ; Conley AP
JAMA Oncol; 2015 Sep; 1(6):797-805. PubMed ID: 26204106
[TBL] [Abstract][Full Text] [Related]
5. Performance of risk stratification systems for gastrointestinal stromal tumors: A multicenter study.
Chen T; Ye LY; Feng XY; Qiu HB; Zhang P; Luo YX; Yuan LY; Chen XH; Hu YF; Liu H; Li Y; Tao KX; Yu J; Li GX
World J Gastroenterol; 2019 Mar; 25(10):1238-1247. PubMed ID: 30886506
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal stromal tumor: 15-years' experience in a single center.
Wang M; Xu J; Zhang Y; Tu L; Qiu WQ; Wang CJ; Shen YY; Liu Q; Cao H
BMC Surg; 2014 Nov; 14():93. PubMed ID: 25403624
[TBL] [Abstract][Full Text] [Related]
7. Integrating bioinformatics and clinicopathological research of gastrointestinal stromal tumors: identification of aurora kinase A as a poor risk marker.
Yen CC; Yeh CN; Cheng CT; Jung SM; Huang SC; Chang TW; Jan YY; Tzeng CH; Chao TC; Chen YY; Yang CY; Ho CL; Fletcher JA
Ann Surg Oncol; 2012 Oct; 19(11):3491-9. PubMed ID: 22588468
[TBL] [Abstract][Full Text] [Related]
8. Re-appraisal of risk classifications for primary gastrointestinal stromal tumors (GISTs) after complete resection: indications for adjuvant therapy.
Yanagimoto Y; Takahashi T; Muguruma K; Toyokawa T; Kusanagi H; Omori T; Masuzawa T; Tanaka K; Hirota S; Nishida T
Gastric Cancer; 2015 Apr; 18(2):426-33. PubMed ID: 24853473
[TBL] [Abstract][Full Text] [Related]
9. [Primary, non-metastatic gastrointestinal stromal tumour surgery: results of the GRISK study].
Artigas Raventós V; López Pousa A; Ortega Medina L; Díaz de Liaño Argüelles A; Fernández Hernández JÁ; Lucena de la Poza JL
Cir Esp; 2013 Feb; 91(2):96-102. PubMed ID: 22748847
[TBL] [Abstract][Full Text] [Related]
10. Risk stratification systems for surgically treated localized primary Gastrointestinal Stromal Tumors (GIST). Review of literature and comparison of the three prognostic criteria: MSKCC Nomogramm, NIH-Fletcher and AFIP-Miettinen.
Belfiori G; Sartelli M; Cardinali L; Tranà C; Bracci R; Gesuita R; Marmorale C
Ann Ital Chir; 2015; 86(3):219-27. PubMed ID: 26098671
[TBL] [Abstract][Full Text] [Related]
11. Subgroups of patients with very large gastrointestinal stromal tumors with distinct prognoses: a multicenter study.
Wada N; Kurokawa Y; Nishida T; Takahashi T; Toyokawa T; Kusanagi H; Hirota S; Tsujinaka T; Mori M; Doki Y
J Surg Oncol; 2014 Feb; 109(2):67-70. PubMed ID: 24155204
[TBL] [Abstract][Full Text] [Related]
12. Prognostic analysis of patients with gastrointestinal stromal tumors: a single unit experience with surgical treatment of primary disease.
Cao H; Zhang Y; Wang M; Shen DP; Sheng ZY; Ni XZ; Wu ZY; Liu Q; Shen YY; Song YY
Chin Med J (Engl); 2010 Jan; 123(2):131-6. PubMed ID: 20137358
[TBL] [Abstract][Full Text] [Related]
13. Prognostic role of tumor necrosis in patients undergoing curative resection for gastric gastrointestinal stromal tumor: a multicenter analysis of 740 cases in China.
Liu X; Qiu H; Zhang P; Feng X; Chen T; Li Y; Tao K; Li G; Sun X; Zhou Z;
Cancer Med; 2017 Dec; 6(12):2796-2803. PubMed ID: 29058376
[TBL] [Abstract][Full Text] [Related]
14. A new nomogram for recurrence-free survival prediction of gastrointestinal stromal tumors: Comparison with current risk classification methods.
Chen T; Xu L; Ye L; Qiu H; Hu Y; Liu H; Zhou Z; Li G; Yu J
Eur J Surg Oncol; 2019 Jun; 45(6):1109-1114. PubMed ID: 30594406
[TBL] [Abstract][Full Text] [Related]
15. Surgery of upper GI gastrointestinal stromal tumors: our experience, prognostic analysis.
Kasetsermwiriya W; Nagai E; Nakata K; Nagayoshi Y; Shimizu S; Tanaka M
Hepatogastroenterology; 2015; 62(137):87-92. PubMed ID: 25911874
[TBL] [Abstract][Full Text] [Related]
16. Audit of a series of 40 gastrointestinal stromal tumour cases.
Hinz S; Pauser U; Egberts JH; Schafmayer C; Tepel J; Fändrich F
Eur J Surg Oncol; 2006 Dec; 32(10):1125-9. PubMed ID: 16859873
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors after surgery of primary resectable gastrointestinal stromal tumours.
Aparicio T; Boige V; Sabourin JC; Crenn P; Ducreux M; Le Cesne A; Bonvalot S
Eur J Surg Oncol; 2004 Dec; 30(10):1098-103. PubMed ID: 15522557
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis.
Gold JS; Gönen M; Gutiérrez A; Broto JM; García-del-Muro X; Smyrk TC; Maki RG; Singer S; Brennan MF; Antonescu CR; Donohue JH; DeMatteo RP
Lancet Oncol; 2009 Nov; 10(11):1045-52. PubMed ID: 19793678
[TBL] [Abstract][Full Text] [Related]
19. Natural history of imatinib-naive GISTs: a retrospective analysis of 929 cases with long-term follow-up and development of a survival nomogram based on mitotic index and size as continuous variables.
Rossi S; Miceli R; Messerini L; Bearzi I; Mazzoleni G; Capella C; Arrigoni G; Sonzogni A; Sidoni A; Toffolatti L; Laurino L; Mariani L; Vinaccia V; Gnocchi C; Gronchi A; Casali PG; Dei Tos AP
Am J Surg Pathol; 2011 Nov; 35(11):1646-56. PubMed ID: 21997685
[TBL] [Abstract][Full Text] [Related]
20. The accuracy of three predictive models in the evaluation of recurrence rates for gastrointestinal stromal tumors.
Racz JM; Brar SS; Cleghorn MC; Jimenez MC; Azin A; Atenafu EG; Jackson TD; Okrainec A; Quereshy FA
J Surg Oncol; 2015 Mar; 111(4):371-6. PubMed ID: 25501790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
